Information  X 
Enter a valid email address

Plant Health Care (PHC)


Wednesday 20 October, 2021

Plant Health Care

Exercise of Options

RNS Number : 7314P
Plant Health Care PLC
20 October 2021


The information communicated in this announcement contains inside information for the purposes of Article 7 of Regulation 596/2014.


Plant Health Care plc


("Plant Health Care" or "the Company")


Exercise of Options,Issue of Equity, Director / PDMR Shareholding

and Total Voting Rights

Plant Health Care, a leading provider of novel patent-protected biological products to global agriculturalmarkets,  announce s that on 20 October 202 1   Christopher Richards, Chief Executive Officer, exercised options (the ' Options ')   awarded under the Company's 2017 Employee Share Option Plan (the ' Plan ').  

As announced on 7 October 2020,the Company had awarded 3,250,000 Options to Christopher Richards with an exercise price of 1p per ordinary share in the Company (the ' Ordinary Shares ') under the Plan that vest upon the earlier of: (a) the date of a Change of Control; or (b) upon satisfaction of the Performance-Based Requirement. The Performance-Based Requirement i n respect of 70% of the O ptions (rounded to the nearest whole number) is that no O ption may be exercised until the date on which the arithmetic mean closing price of the Ordinary S hares over 30 consecutive trading dates after the date of grant has exceeded 15p per S hare . This criteria was achieved earlier this year and Dr Richards has now decided to exercise 2,275,000Options.

Of the 2,275,000 Ordinary Shares to be issued(the ' New Ordinary Shares ') following the exercise of the Options, Christopher Richards has sold879,042Ordinary Shares at an aggregate price of £100,146.06, being enough Ordinary Shares to cover the exercise price and associated tax liabilities in respect of the Ordinary Shares issued. Following these transactions, Dr Richards is interested in 4,370,973 Ordinary Shares representing 1.43% of the issued share capital of the Company.


Application for admission of the New   Ordinary Shares to trading on AIM ('Admission') has been made and dealings in the New Ordinary Shares are expected to commence at 8.00 a.m. on 26 October 2021. The New Ordinary Shares will rank pari-passu with the Company's existing issued Ordinary Shares.


Total voting rights


Following Admission, the Company will have 304,662,482 Ordinary Shares in issue with no shares held in treasury. This is the total number of voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.






Plant Health Care plc

+1 919 926 1600

Richard Webb - Chairman


Arden Partners plc - Nomad and Joint Broker

John Llewellyn-Lloyd / Antonio Bossi


+44 (0)20 7614 5900

Cenkos Securities plc - Joint Broker

Neil McDonald / Peter Lynch

+44 (0) 20 7391 8900

Company website:  

The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.



Details of the person discharging managerial responsibilities/person closely associated



Dr Christopher Richards


Reason for the notification



Chief Executive Officer


Initial notification/Amendment

Initial notification


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor



Plant Health Care plc







Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted


Description of the financial instrument, type of instrument


Identification code

Options over Ordinary Shares of 1p each



Nature of the transaction

Sale of Shares following exercise of options


Price(s) and volume(s)






Aggregated information


Aggregated volume







Date of the transaction

20.10. 202 1


Place of the transaction

AIM, London Stock Exchange









This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t